Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
95 Cards in this Set
- Front
- Back
Somatostatin (SRIF) analog used for acromegaly, carcinoid, glucagonoma and other GH producing pituitary tumors
|
Octreotide
|
|
Somatotropin (GH) analog used in GH deficiency (dwarfism)
|
Somatrem
|
|
GHRH analog used as diagnostic agent
|
Sermorelin
|
|
GnRH agonist used for infertility or different types of CA depending on pulsatile or steady usage respectively
|
Leuprolide
|
|
GnRH antagonist with more immediate effects, used for infertility
|
Ganirelix
|
|
Dopamine (DA) agonist (for Parkinson's disease), used also for hyperprolactinemia
|
Bromocriptine
|
|
Hormone inhibiting prolactin release
|
Dopamine
|
|
ACTH analog used for diagnosis of patients with corticosteroid abnormality
|
Cosyntropin
|
|
Synthetic analog of ADH hormone used for diabetes insipidus and nocturnal enuresis
|
Desmopressin (DDAVP)
|
|
Most widely used thyroid drugs such as Synthroid and Levoxyl contain
|
L-thyroxine (T4)
|
|
T3 compound less widely used
|
Cytomel
|
|
Anti-thyroid drugs
|
Thioamides, iodides, radioactive iodine, and ipodate
|
|
Thioamide agents used in hyperthyroidism
|
Methimazole and propylthiouracil (PTU)
|
|
Thioamide less likely to cross placenta, inhibits peripheral conversion of T4 to T3 in high doses, and should be used with extreme caution in pregnancy
|
PTU
|
|
PTU (propylthiouracil) MOA
|
Inhibits thyroid hormone synthesis by blocking iodination of the tyrosine residues of thyroglobulin
|
|
Can be effective for short term therapy of thyroid storm, but after several weeks of therapy causes an exacerbation of hyperthyroidism
|
Iodide salts
|
|
Permanently cures thyrotoxicosis, patients will need thyroid replacement therapy thereafter. Contraindicated in pregnancy
|
Radioactive iodine
|
|
Radio contrast media that inhibits the conversion of T4 to T3
|
Ipodate
|
|
Block cardiac adverse effects of thyrotoxicosis such as tachycardia, inhibits the conversion of T4 to T3
|
Beta-blockers such as propranolol
|
|
Pneumonic for 3 zones of adrenal cortex
|
GFR
|
|
Used for Addison's disease, Congenital Adrenal Hyperplasia (CAH), inflammation, allergies, and asthma (as a local inhalation)
|
Glucocorticoids
|
|
Short acting GC's
|
Cortisone and hydrocortisone (equivalent to cortisol)
|
|
Intermediate acting GC's
|
Prednisone, methylprednisolone, prednisolone, and triamcinolone
|
|
Long acting GC's
|
Betamethasone, dexamethasone, and paramethasone
|
|
Mineralocorticoids
|
Fludrocortisone and deoxycorticosterone
|
|
Some side effects of corticosteroids
|
Osteopenia, impaired wound healing, inc. risk of infection, inc. appetite, HTN, edema, PUD, euphoria, psychosis
|
|
Period of time of therapy after which GC therapy will need to be tapered
|
5-7 days
|
|
Used for Cushing's syndrome (increased corticosteroid) and sometimes for adrenal function test
|
Metyrapone
|
|
Inhibits conversion of cholesterol to pregnenolone therefore inhibiting corticosteroid synthesis
|
Aminoglutethimide
|
|
Antifungal agent used for inhibition of all gonadal and adrenal steroids
|
Ketoconazole
|
|
Antiprogestin used as potent antagonist of GC receptor
|
Mifepristone
|
|
Diuretic used to antagonize aldosterone receptors
|
Spironolactone
|
|
Common SE of spironolactone
|
Gynecomastia and hyperkalemia
|
|
Slightly increased risk of breast cancer, endometrial cancer, heart disease (questionable), has beneficial effects on bone loss
|
Estrogen
|
|
Antiestrogen drugs used for fertility and breast cancer respectively
|
Clomiphene and tamoxifen
|
|
Common SE of tamoxifen and raloxifene
|
Hot flashes
|
|
Selective estrogen receptor modulator (SERM) used for prevention of osteoporosis and currently being tested for treatment of breast cancer (Stars study)
|
Raloxifene
|
|
Non-steroidal estrogen agonist causes clear cell adenocarcinoma of the vagina in daughters of women who used it during pregnancy
|
Diethylstilbestrol (DES)
|
|
Estrogen mostly used in oral contraceptives (OC)
|
Ethinyl estradiol and mestranol
|
|
Anti-progesterone used as abortifacient
|
Mifepristone (RU-486)
|
|
Constant low dose of estrogen and increasing dose of progestin for 21 days (last 5 days are sugar pills or iron prep)
|
Combination oral contraceptives (OC)
|
|
Oral contraceptive available in a transdermal patch
|
Ortho-Evra
|
|
Converted to more active form DHT by 5 alpha-reductase
|
Testosterone
|
|
5 alpha-reductase inhibitor used for benign prostatic hyperplasia (BPH) and male pattern baldness
|
Finasteride (Proscar and Propecia respectively)
|
|
Anabolic steroid that has potential for abuse
|
Nandrolone and stanozolol
|
|
Anti-androgen used for hirsutism in females
|
Cyproterone acetate
|
|
Drug is used with testosterone for male fertility
|
Leuprolide
|
|
Alpha cells in the pancreas
|
Produce glucagon
|
|
Beta cells in the pancreas
|
Produce insulin
|
|
Beta cells are found
|
Islets of Langerhans
|
|
Delta cells in the pancreas
|
Produce Somatostatin
|
|
Product of proinsulin cleavage used to assess insulin abuse
|
C-peptide
|
|
Exogenous insulin
|
Little C-peptide
|
|
Endogenous insulin
|
Normal C-peptide
|
|
Very rapid acting insulin, having fastest onset and shortest duration of action
|
Lispro (Humalog)
|
|
Rapid acting, crystalline zinc insulin used to reverse acute hyperglycemia
|
Regular (Humulin R)
|
|
Long acting insulin
|
Ultralente (humulin U)
|
|
Ultra long acting insulin, has over a day duration of action
|
Glargine (Lantus)
|
|
Major SE of insulin
|
Hypoglycemia
|
|
Important in synthesis of glucose to glycogen in the liver
|
GLUT 2
|
|
Important in muscle and adipose tissue for glucose transport across muscles and TG storage by lipoprotein lipase activation
|
GLUT 4
|
|
Examples of alpha-glucosidase inhibitors (AGI)
|
Acarbose, miglitol
|
|
MOA of AGI's
|
Act on intestine, delay absorption of glucose
|
|
SE of AGI's
|
Flatulence (do not use beano to tx), diarrhea, abdominal cramps
|
|
Alpha-glucosidase inhibitor associated with elevation of LFT's
|
Acarbose
|
|
Amino acid derivative
|
Nateglinide
|
|
MOA of nateglinide
|
Insulin secretagogue
|
|
Biguanide
|
Metformin
|
|
Drugs available in combination with metformin
|
Glyburide, glipizide, and rosiglitazone
|
|
MOA of metformin
|
Decreases hepatic glucose production and intestinal glucose absorption; increase insulin sensitivity
|
|
Most important potential SE of metformin
|
Lactic acidosis
|
|
Meglitinide
|
Repaglinide
|
|
MOA of repaglinide
|
Insulin release from pancreas; faster and shorter acting than sulfonylurea
|
|
First generation sulfonylurea
|
Chlorpropamide, tolbutamide, tolazamide, etc.
|
|
Second generation sulfonylurea
|
Glyburide, glipizide, glimepiride, etc.
|
|
MOA of both generations
|
Insulin release from pancreas by modifying K+ channels
|
|
Common SE of sulfonylureas, repaglinide, and nateglinide
|
Hypoglycemia
|
|
Sulfonylurea NOT recommended for elderly because of very long half life
|
Chlorpropamide
|
|
Thiazolidinediones
|
Pioglitazone, Rosiglitazone, Troglitazone (withdrawn/d from market)
|
|
Reason troglitazone was withdrawn from market
|
Hepatic toxicity
|
|
MOA of thiazolindinediones
|
Stimulate PPAR-gamma receptor to regulate CHO and lipid metabolism
|
|
SE of Thiazolindinediones
|
Edema, mild anemia; interaction with drugs that undergo CytP450 3A4 metabolism
|
|
Hyperglycemic agent that increases cAMP and results in glycogenolysis, gluconeogenesis, reverses hypoglycemia, also used to reverse severe beta-blocker overdose and smooth muscle relaxation
|
Glucagon
|
|
Available bisphosphonates
|
Alendronate, etidronate, risedronate, pamidronate, tiludronate, and zoledronic acid
|
|
MOA of Bisphosphonates
|
Inhibits osteoclast bone resorption
|
|
Only bisphosphonates available IV
|
Etidronate
|
|
Uses of bisphosphonates
|
Osteoporosis, Paget's disease, and osteolytic bone lesions, and hypercalcemia from malignancy
|
|
Major SE of bisphosphonates
|
Chemical esophagitis
|
|
Bisphosphonates that cannot be used on continuous basis because it caused osteomalacia
|
Etidronate
|
|
Used for prevention of postmenopausal osteoporosis in women
|
Estrogen (HRT-Hormone replacement therapy)
|
|
Increase bone density, also being tested for breast CA tx.
|
Raloxifene (SERM-selective estrogen receptor modulator)
|
|
Used intranasally and decreases bone resorption
|
Calcitonin (salmon prep)
|
|
Used especially in postmenopausal women, dosage should be 1500 mg
|
Calcium
|
|
Vitamin given with calcium to ensure proper absorption
|
Vitamin D
|
|
3 zones of adrenal cortex and their products
|
Glomerulosa (mineralocorticoids), fasciculata (glucocorticoid=GC), and reticularis (adrenal androgens)
|